CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Glaxo Smithkline Consumer Nigeria PLC Company Snapshot
Glaxo Smithkline Consumer Nigeria PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smithkline Consumer Nigeria PLC with three other pharmaceutical manufacturers in Africa: Fidson Healthcare Limited (2018 sales of 16.23 billion Naira [US$52.91 million] ), Societe Adwya SA of Tunisia (108.18 million Dinar [US$38.12 million] of which 59% was Pharmacy), and Promopharm SA which is based in Morocco (444.53 million Moroccan Dirhams [US$46.03 million] ).

Sales Analysis. During the year ended December of 2018, sales at Glaxo Smithkline Consumer Nigeria PLC were 18.41 billion Naira (US$60.02 million). This is an increase of 14.4% versus 2017, when the company's sales were 16.09 billion Naira. Sales of Pharmaceuticals saw an increase of 15.4% in 2018, from 10.36 billion Naira to 11.95 billion Naira.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Glaxo Smithkline Consumer Nigeria PLC
  Stock Performance Chart for Glaxo Smithkline Consumer Nigeria PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 7.10
(Figures in Naira)
1 Week 0.0%   13 Weeks -2.1%  
4 Weeks -14.5%   52 Weeks -49.5%  
 
Glaxo Smithkline Consumer Nigeria PLC Key Data:
  Ticker: GLAXOSMITH Country: Nigeria
  Exchanges: NIG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 18,411,475,000
(Year Ending Jan 2019).
Employees: 131
  Currency: Naira Market Cap: 8,490,719,600
  Fiscal Yr Ends: December Shares Outstanding: 1,195,876,000
  Share Type: Closely Held Shares: 555,081,925
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.